• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 3. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 4. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 5. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Aminopiperidines

Research Brief on (3S)-N-methylpiperidin-3-amine (CAS: 80918-67-8) in Chemical Biology and Pharmaceutical Applications

The compound (3S)-N-methylpiperidin-3-amine (CAS: 80918-67-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential as a versatile building block for drug discovery and development. This research brief synthesizes the latest findings on its synthesis, pharmacological properties, and applications in medicinal chemistry.

Recent studies highlight the role of (3S)-N-methylpiperidin-3-amine as a key intermediate in the synthesis of bioactive molecules targeting central nervous system (CNS) disorders. Its chiral piperidine scaffold is particularly valuable for designing selective ligands for neurotransmitter receptors, including dopamine and serotonin receptors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in improving the blood-brain barrier permeability of derived compounds, a critical factor in CNS drug development.

In synthetic chemistry, novel catalytic asymmetric methods have been developed to produce (3S)-N-methylpiperidin-3-amine with high enantiomeric purity (>99% ee). These advancements, reported in Angewandte Chemie, utilize chiral palladium catalysts and have significantly improved the scalability of this compound for industrial applications. The CAS: 80918-67-8 specification has become particularly important for quality control in these synthetic routes.

Pharmacological evaluations have revealed that derivatives of (3S)-N-methylpiperidin-3-amine show promising activity as sigma-1 receptor modulators, with potential applications in neuropathic pain management and neurodegenerative diseases. Structure-activity relationship (SAR) studies published in Bioorganic & Medicinal Chemistry Letters (2024) identified specific structural modifications that enhance receptor binding affinity while maintaining favorable pharmacokinetic properties.

The compound's safety profile has been extensively studied, with recent toxicological data indicating good tolerability in preclinical models. However, researchers emphasize the need for careful consideration of its metabolic pathways, as certain cytochrome P450 enzymes have been shown to mediate its biotransformation in liver microsome studies.

Looking forward, (3S)-N-methylpiperidin-3-amine continues to be a focus of innovation in drug discovery. Current research directions include its incorporation into PROTAC molecules for targeted protein degradation and exploration as a fragment in DNA-encoded library technology. The unique spatial arrangement of its functional groups makes it particularly valuable for these emerging therapeutic modalities.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)